Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

224.78B

Market cap224.78B

Price-Earnings ratio

15.97

Price-Earnings ratio15.97

Dividend yield

2.19%

Dividend yield2.19%

Average volume

18.73M

Average volume18.73M

High today

$52.34

High today$52.34

Low today

$52.01

Low today$52.01

Open price

$53.97

Open price$53.97

Volume

1.63M

Volume1.63M

52 Week high

$139.74

52 Week high$139.74

52 Week low

$52.01

52 Week low$52.01

NVO News

Seeking Alpha 50m

Novo Nordisk continues to slip after outlook cut, obesity drug worries

Novo Nordisk (NVO) continued its downward spiral and fell 3.8% in premarket trade, a day after the Danish drugmaker slashed its full-year outlook, weighed down...

NPR 16h

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding - NPR

...

CNBC 1d

Novo Nordisk shares plunge 15% after Wegovy-maker cuts full-year guidance

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Danish pharmaceutical giant Novo Nordisk on Tuesday...

Analyst ratings

56%

of 32 ratings

Buy

56.3%

Hold

34.4%

Sell

9.4%